Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Europese Unie - Kroatisch - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

STALEVO 100 mg/1 tableta+ 25 mg/1 tableta+ 200 mg/1 tableta film tableta Bosnië en Herzegovina - Kroatisch - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

stalevo 100 mg/1 tableta+ 25 mg/1 tableta+ 200 mg/1 tableta film tableta

novartis ba d.o.o. - энтакапон, karbidopa, леводопы - film tableta - 100 mg/1 tableta+ 25 mg/1 tableta+ 200 mg/1 tableta - 1 film tableta sadrži: 100 mg levodope, 25 mg karbidope (u obliku karbidopa, monohidrata) i 200 mg entakapona

TOBRADEX 3 mg/1 mL+ 1 mg/1 mL kapi za oči, suspenzija Bosnië en Herzegovina - Kroatisch - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

tobradex 3 mg/1 ml+ 1 mg/1 ml kapi za oči, suspenzija

novartis ba d.o.o. - дексаметазон, na primjer тобрамицина - kapi za oči, suspenzija - 3 mg/1 ml+ 1 mg/1 ml - 1 ml suspenzije sadrži: 3 mg tobramicina 1 mg deksametazona